Letter to the Editor

Page 2

Recently published articles about Letter to the Editor

JCP
Ketamine-Associated Uropathy in Therapeutic Contexts: Reply to Abdelrahman
Letter to the Editor

January 26, 2026

Dr Andrade responds to a letter commenting on his recent review of ketamine-associated uropathy in therapeutic and nontherapeutic settings.
PCC
Kratom-Induced Psychosis
Letter to the Editor

January 8, 2026

The author comments on the complexity of substance-induced presentations, particularly those related to newly available psychoactive substances such as kratom.
PCC
Semaglutide for Alcohol Use Disorder
Letter to the Editor

January 1, 2026

The authors explore potential mechanisms underlying the relationship between GLP-1 agonists and AUD as well as studies evaluating semaglutide for AUD.
,
JCP
Reframing the Discussion on Finasteride and Neuropsychiatric Safety
Letter to the Editor

December 17, 2025

The authors comment on a recent article by Brezis, who argues that finasteride is causally linked to depression, suicidality, and other neuropsychiatric reactions.
,
JCP
Finasteride-Induced Neuropsychiatric Reactions: No Room for Complacency
Letter to the Editor

December 17, 2025

Dr Brezis replies to a letter by Tringali and Tringali regarding his recent article.
PCC
Psychosis Screening in Genetic Disorders
Letter to the Editor

December 4, 2025

The author discusses routine monitoring for the development of psychotic symptoms among individuals with rare genetic disorders that confer risk for psychosis.
PCC
Culturally Adaptive Mental Health Care
Letter to the Editor

December 2, 2025

The author discusses the culturally adaptive work of Dr Vidya Sagar, whose mid-20th-century innovations in family-centered care laid the groundwork for India’s unique trajectory in community psychiatry.
JCP
Burnout in Psychiatric Doctors Before and After COVID-19: A Critical Commentary
Letter to the Editor

December 1, 2025

The authors comment on a recent meta-analysis by Johnson and colleagues.
,
JCP
Exposure Therapy for Perinatal OCD: Navigating Evidence and Discomfort
Letter to the Editor

November 17, 2025

Although patients and providers must be prepared for the temporary distress associated with exposure and response prevention, it remains the most effective nonpharmacologic treatment for OCD.
, ,
JCP
From Today’s Observations to Tomorrow’s Standards in Women’s Psychiatry
Letter to the Editor

November 3, 2025

The authors comment on a recent study of treatment use and preference in women with mood disorders.
, ,
JCP
Context Matters in Treatment Preference of Women With Mood Disorders: Reply to Świeczkowski et al
Letter to the Editor

November 3, 2025

The authors reply to Świeczkowski and colleagues’ letter regarding their recent study
,
JCP
Racemic Ketamine vs Esketamine in Treatment-Resistant Depression: The Overlooked Role of Arketamine
Letter to the Editor

October 29, 2025

The authors comment on a recent chart review by Meisner et al.
,

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe